We are live on ! Find out more
MH

Mark Hillman Hillman Capital Management

AUM $138M
1-Year Est. Return 8.57%
 

Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.

This Fund
S&P 500
This Quarter Est. Return
+4.22%
1 Year Est. Return
+8.57%
3 Year Est. Return
+20.19%
5 Year Est. Return
+18.79%
10 Year Est. Return
AUM
$292M
AUM Growth
+$8.35M
Cap. Flow
-$1.32M
Cap. Flow %
-0.45%
Top 10 Hldgs %
32.89%
Holding
56
New
3
Increased
25
Reduced
19
Closed
4

Top Buys

Rank Stock Value
1
NUE icon
Nucor
NUE
+$6.46M
2
ZBH icon
Zimmer Biomet
ZBH
+$3.75M
3
NKE icon
Nike
NKE
+$1.29M
4
EL icon
Estee Lauder
EL
+$1.25M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.23M

Top Sells

Rank Stock Value
1
K
Kellanova
K
+$8.28M
2
BNY
Bank of New York Mellon
BNY
+$6.72M
3
ADBE icon
Adobe
ADBE
+$2.25M
4
SPG icon
Simon Property Group
SPG
+$803K
5
MMM icon
3M
MMM
+$294K

Sector Composition

Rank Sector Weight
1 Healthcare 21.02%
2 Communication Services 15.41%
3 Consumer Staples 13.38%
4 Consumer Discretionary 10.97%
5 Technology 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
51
iShares Core S&P 500 ETF
IVV
$893B
$238K 0.08%
412
IWR icon
52
iShares Russell Mid-Cap ETF
IWR
$57.7B
$219K 0.08%
2,482
+3
+0.1% +$253
BNY
53
Bank of New York Mellon
BNY
$108B
-112,230
Closed -$6.72M
BLK icon
54
Blackrock
BLK
$179B
-349
Closed -$275K
K
55
DELISTED
Kellanova
K
-143,491
Closed -$8.28M
MMM icon
56
3M
MMM
$92.3B
-2,881
Closed -$294K

Similar funds

Mark Hillman's Q3 2024 Portfolio in Review

As of Q3 2024, Mark Hillman held 56 positions worth $292M, up 2.9% from $283M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Mark Hillman's Q3 2024 filing shows 3 new, 25 increased, 19 reduced and 4 closed positions. Its largest new stake was Nucor: 42,943 shares worth $6.46M. The largest sale was Kellanova, an estimated $8.28M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Consumer Staples.

  • Mark Hillman's largest Q3 2024 buy was Nucor: 42,943 shares worth $6.46M.
  • Mark Hillman added most to Zimmer Biomet in Q3 2024, an estimated $3.75M increase.
  • Mark Hillman's biggest Q3 2024 reduction was Adobe, cutting an estimated $2.25M.
  • Mark Hillman fully exited Kellanova in Q3 2024, selling an estimated $8.28M.
  • Mark Hillman's ten largest holdings make up 33% of its $292M portfolio in Q3 2024.
  • Mark Hillman opened 3 new positions and closed 4 in Q3 2024.
  • Mark Hillman's portfolio value rose 2.9% quarter-over-quarter to $292M.

Based on Hillman Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.